Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 16, 2013

View Archived Issues

Novel transgenic pig model of familial hypercholesterolemia

Vertex Pharmaceuticals synthesizes new protein kinase inhibitors

Argos Therapeutics enrolls first patients in phase III ADAPT study

Researchers at Amgen present novel TRPM8 antagonists

The Wisconsin Alumni Research Foundation patents novel vitamin D analogues

Celecoxib shows promise as adjunctive treatment in children with autism

AstraZeneca and Vanderbilt University enter collaboration

Galapagos delivers second candidate drug to Janssen Pharmaceutica

French grant awarded for development of epicutaneous pediatric RSV vaccine

Four NIH-supported studies focus on new treatments for Alzheimer's disease

CorMedix signs marketing agreement with MKM Co-Pharma for Neutrolin

Cytos updates on phase IIb allergic asthma study

Tysabri label update sought from the FDA and EMA

Detection of endometrial and ovarian cancers through DNA screening of Pap smears

European approval for Amyvid diagnostic radiopharmaceutical

FDA accepts for filing Tarceva sNDA

Unigene Laboratories designs polypeptides with anti-inflammatory activity

Isis Pharmaceuticals patents antisense modulators of FGFR-4

European approval for new 800-mg tablet of Prezista

Novel GnRH receptor antagonists emerge from Bayer R&D

New antidiabetic agents described in Metabolic Solutions Development patent

Zenobia Therapeutics develops novel LRRK2 inhibitors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...